{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:08:33Z","timestamp":1788880113484,"version":"build-2803163510"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"DST-SERB"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.biopha.2016.04.022","type":"journal-article","created":{"date-parts":[[2016,4,25]],"date-time":"2016-04-25T14:31:01Z","timestamp":1461594661000},"page":"250-257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Histone deacetylase inhibitor sulforaphane: The phytochemical with vibrant activity against prostate cancer"],"prefix":"10.1016","volume":"81","author":[{"given":"Shabir Ahmad","family":"Ganai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2016.04.022_bib0005","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4161\/epi.3.6.7273","article-title":"The role of histone deacetylases in prostate cancer","volume":"3","author":"Abbas","year":"2008","journal-title":"Epigenetics"},{"key":"10.1016\/j.biopha.2016.04.022_bib0010","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc1779","article-title":"Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer","volume":"6","author":"Minucci","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2016.04.022_bib0015","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.1073\/pnas.052410099","article-title":"Comprehensive analysis of CpG islands in human chromosomes 21 and 22","volume":"99","author":"Takai","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2016.04.022_bib0020","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1038\/sj.onc.1210599","article-title":"HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention","volume":"26","author":"Yang","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2016.04.022_bib0025","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2174\/1568026615666150813145800","article-title":"Panobinostat: the small molecule metalloenzyme inhibitor with marvelous anticancer activity","volume":"16","author":"Ganai","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.biopha.2016.04.022_bib0030","doi-asserted-by":"crossref","first-page":"9322","DOI":"10.1039\/c2sm25662b","article-title":"The polyelectrolyte properties of chromatin","volume":"8","author":"Korolev","year":"2012","journal-title":"Soft Matter"},{"key":"10.1016\/j.biopha.2016.04.022_bib0035","first-page":"1","article-title":"Strategy for enhancing the therapeutic efficacy of histone deacetylase inhibitor dacinostat: the novel paradigm to tackle monotonous cancer chemoresistance","author":"Ganai","year":"2015","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.biopha.2016.04.022_bib0040","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1586\/era.10.62","article-title":"Nonhistone protein acetylation as cancer therapy targets","volume":"10","author":"Singh","year":"2010","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.biopha.2016.04.022_bib0045","first-page":"1","article-title":"Histone deacetylase inhibitor pracinostat in doublet therapy: a unique strategy to improve therapeutic efficacy and to tackle herculean cancer chemoresistance","author":"Ganai","year":"2016","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.biopha.2016.04.022_bib0050","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1073\/pnas.0307708100","article-title":"Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1","volume":"101","author":"Gui","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2016.04.022_bib0055","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1128\/MCB.23.8.2669-2679.2003","article-title":"The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21\/WAF1\/CIP1 gene","volume":"23","author":"Lagger","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.biopha.2016.04.022_bib0060","doi-asserted-by":"crossref","first-page":"13548","DOI":"10.1074\/jbc.M510023200","article-title":"Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer","volume":"281","author":"Wilson","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2016.04.022_bib0065","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1096\/fj.04-2303fje","article-title":"Histone deacetylase HDAC8 associates with smooth muscle alpha-actin and is essential for smooth muscle cell contractility","volume":"19","author":"Waltregny","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2016.04.022_bib0070","doi-asserted-by":"crossref","first-page":"15064","DOI":"10.1073\/pnas.0404603101","article-title":"Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor","volume":"101","author":"Vannini","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2016.04.022_bib0075","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/417455a","article-title":"HDAC6 is a microtubule-associated deacetylase","volume":"417","author":"Hubbert","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2016.04.022_bib0080","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.tcb.2008.04.003","article-title":"HDAC6: a key regulator of cytoskeleton, cell migration and cell\u2013cell interactions","volume":"18","author":"Valenzuela-Fernandez","year":"2008","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.biopha.2016.04.022_bib0085","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4161\/cc.7.1.5186","article-title":"HDAC6 a new cellular stress surveillance factor","volume":"7","author":"Matthias","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.biopha.2016.04.022_bib0090","doi-asserted-by":"crossref","first-page":"16663","DOI":"10.1073\/pnas.0908908106","article-title":"Sulforaphane destabilizes the androgen receptor in prostate cancer cells by inactivating histone deacetylase 6","volume":"106","author":"Gibbs","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2016.04.022_bib0095","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bbrc.2008.01.056","article-title":"Class II histone deacetylases play pivotal roles in heat shock protein 90-mediated proteasomal degradation of vascular endothelial growth factor receptors","volume":"368","author":"Park","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2016.04.022_bib0100","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2174\/1570159X13666151021111609","article-title":"Histone Deacetylase (HDAC) Inhibitors \u2212 emerging roles in neuronal memory, learning, synaptic plasticity and neural regeneration","volume":"14","author":"Ganai","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.biopha.2016.04.022_bib0105","doi-asserted-by":"crossref","first-page":"388","DOI":"10.2174\/138920107783018417","article-title":"Histone deacetylase inhibitors in cancer treatment: a review of the clinical toxicity and the modulation of gene expression in cancer cell","volume":"8","author":"Bruserud","year":"2007","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.biopha.2016.04.022_bib0110","article-title":"Novel approaches towards designing of isoform-selective inhibitors against class II histone deacetylases: the acute requirement for targetted anticancer therapy","author":"Ganai","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.biopha.2016.04.022_bib0115","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/1471-2407-12-180","article-title":"Plant HDAC inhibitor chrysin arrest cell growth and induce p21WAF1 by altering chromatin of STAT response element in A375 cells","volume":"12","author":"Pal-Bhadra","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biopha.2016.04.022_bib0120","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1016\/j.bmcl.2007.06.060","article-title":"Pomiferin, histone deacetylase inhibitor isolated from the fruits of Maclura pomifera","volume":"17","author":"Son","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2016.04.022_bib0125","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.1158\/0008-5472.CAN-04-1326","article-title":"A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase","volume":"64","author":"Myzak","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2016.04.022_bib0130","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.18632\/oncotarget.1764","article-title":"Sulforaphane counteracts aggressiveness of pancreatic cancer driven by dysregulated Cx43-mediated gap junctional intercellular communication","volume":"5","author":"Forster","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2016.04.022_bib0135","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/01635581.2011.523500","article-title":"Prolonged sulforaphane treatment activates survival signaling in nontumorigenic NCM460 colon cells but apoptotic signaling in tumorigenic HCT116 colon cells","volume":"63","author":"Zeng","year":"2011","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.biopha.2016.04.022_bib0140","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1158\/1078-0432.CCR-09-2937","article-title":"Sulforaphane, a dietary component of broccoli\/broccoli sprouts, inhibits breast cancer stem cells","volume":"16","author":"Li","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2016.04.022_bib0145","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1155\/2013\/415078","article-title":"Sulforaphane as a potential protective phytochemical against neurodegenerative diseases","volume":"2013","author":"Tarozzi","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biopha.2016.04.022_bib0150","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.jnutbio.2011.11.004","article-title":"Sulforaphane inhibits pancreatic cancer through disrupting Hsp90-p50(Cdc37) complex and direct interactions with amino acids residues of Hsp90","volume":"23","author":"Li","year":"2012","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.biopha.2016.04.022_bib0155","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/mt.2010.216","article-title":"Sulforaphane increases drug-mediated cytotoxicity toward cancer stem-like cells of pancreas and prostate","volume":"19","author":"Kallifatidis","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biopha.2016.04.022_bib0160","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canlet.2008.08.016","article-title":"HDAC family: what are the cancer relevant targets","volume":"277","author":"Witt","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2016.04.022_bib0165","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1139\/o01-116","article-title":"The emerging role of class II histone deacetylases","volume":"79","author":"Fischle","year":"2001","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.biopha.2016.04.022_bib0170","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.3390\/molecules20033898","article-title":"Histone deacetylase inhibitors in clinical studies as templates for new anticancer agents","volume":"20","author":"Mottamal","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2016.04.022_bib0175","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.molonc.2007.01.001","article-title":"The role of histone deacetylases (HDACs) in human cancer","volume":"1","author":"Ropero","year":"2007","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.biopha.2016.04.022_bib0180","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd2133","article-title":"Anticancer activities of histone deacetylase inhibitors","volume":"5","author":"Bolden","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2016.04.022_bib0185","first-page":"47","article-title":"Histone deacetylase inhibitors (HDACIs): multitargeted anticancer agents","volume":"7","author":"Ververis","year":"2013","journal-title":"Biologics"},{"key":"10.1016\/j.biopha.2016.04.022_bib0190","first-page":"1","article-title":"HDAC inhibitors entinostat and suberoylanilide hydroxamic acid (SAHA): the ray of hope for cancer therapy","author":"Ganai","year":"2015","journal-title":"Mol. Life Sci."},{"key":"10.1016\/j.biopha.2016.04.022_bib0195","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1021\/jm030990+","article-title":"3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamides as a new class of synthetic histone deacetylase inhibitors 2. Effect of pyrrole-C2 and\/or -C4 substitutions on biological activity","volume":"47","author":"Mai","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2016.04.022_bib0200","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1039\/b703830p","article-title":"Isoform-selective histone deacetylase inhibitors","volume":"37","author":"Bieliauskas","year":"2008","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biopha.2016.04.022_bib0205","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1042\/BJ20070779","article-title":"Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors","volume":"409","author":"Khan","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.biopha.2016.04.022_bib0210","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1080\/07391102.2013.879073","article-title":"Energy-optimised pharmacophore approach to identify potential hotspots during inhibition of Class II HDAC isoforms","volume":"33","author":"Ganai","year":"2015","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.biopha.2016.04.022_bib0215","first-page":"1","article-title":"In silico approaches towards safe targeting of class I histone deacetylases. I","author":"Ganai","year":"2015","journal-title":"Mol. Life Sci."},{"key":"10.1016\/j.biopha.2016.04.022_bib0220","doi-asserted-by":"crossref","first-page":"22429","DOI":"10.1016\/S0021-9258(18)41547-5","article-title":"Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase","volume":"268","author":"Kijima","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2016.04.022_bib0225","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1016\/j.bmc.2005.12.063","article-title":"Chlamydocin analogs bearing carbonyl group as possible ligand toward zinc atom in histone deacetylases","volume":"14","author":"Bhuiyan","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.biopha.2016.04.022_bib0230","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/pros.20022","article-title":"Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer","volume":"59","author":"Halkidou","year":"2004","journal-title":"Prostate"},{"key":"10.1016\/j.biopha.2016.04.022_bib0235","first-page":"769","article-title":"Expression profile of class I histone deacetylases in human cancer tissues","volume":"18","author":"Nakagawa","year":"2007","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2016.04.022_bib0240","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.eururo.2003.10.005","article-title":"Nuclear accumulation of histone deacetylase 4 (HDAC4) coincides with the loss of androgen sensitivity in hormone refractory cancer of the prostate","volume":"45","author":"Halkidou","year":"2004","journal-title":"Eur. Urol."},{"key":"10.1016\/j.biopha.2016.04.022_bib0245","doi-asserted-by":"crossref","first-page":"51218","DOI":"10.1074\/jbc.M409271200","article-title":"Cytoplasmic sequestration of HDAC7 from mitochondrial and nuclear compartments upon initiation of apoptosis","volume":"279","author":"Bakin","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2016.04.022_bib0250","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.bbrc.2008.06.045","article-title":"A role for SIRT1 in cell growth and chemoresistance in prostate cancer PC3 and DU145 cells","volume":"373","author":"Kojima","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2016.04.022_bib0255","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1210\/me.2006-0467","article-title":"Sirtuin 1 is required for antagonist-induced transcriptional repression of androgen-responsive genes by the androgen receptor","volume":"21","author":"Dai","year":"2007","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.biopha.2016.04.022_bib0260","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0889-1575(03)00045-0","article-title":"Variation in content of bioactive components in broccoli","volume":"16","author":"Jeffery","year":"2003","journal-title":"J. Food Compost. Anal."},{"key":"10.1016\/j.biopha.2016.04.022_bib0265","first-page":"125","article-title":"Glucoraphanin, the bioprecursor of the widely extolled chemopreventive agent sulforaphane found in broccoli, induces phase-I xenobiotic metabolizing enzymes and increases free radical generation in rat liver","volume":"595","author":"Perocco","year":"2006","journal-title":"Mutation Res"},{"key":"10.1016\/j.biopha.2016.04.022_bib0270","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1021\/jf051823g","article-title":"Evaporative light-scattering analysis of sulforaphane in broccoli samples: quality of broccoli products regarding sulforaphane contents","volume":"54","author":"Nakagawa","year":"2006","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.biopha.2016.04.022_bib0275","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/BF00019299","article-title":"The myrosinase (thioglucoside glucohydrolase) gene family in Brassicaceae","volume":"23","author":"Thangstad","year":"1993","journal-title":"Plant Mol. Biol."},{"key":"10.1016\/j.biopha.2016.04.022_bib0280","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1021\/jf0525277","article-title":"Epithiospecifier protein from broccoli (Brassica oleracea L. ssp. italica) inhibits formation of the anticancer agent sulforaphane","volume":"54","author":"Matusheski","year":"2006","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.biopha.2016.04.022_bib0285","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.phytochem.2004.04.013","article-title":"Heating decreases epithiospecifier protein activity and increases sulforaphane formation in broccoli","volume":"65","author":"Matusheski","year":"2004","journal-title":"Phytochemistry"},{"key":"10.1016\/j.biopha.2016.04.022_bib0290","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1002\/mnfr.201200225","article-title":"Isothiocyanate concentrations and interconversion of sulforaphane to erucin in human subjects after consumption of commercial frozen broccoli compared to fresh broccoli","volume":"56","author":"Saha","year":"2012","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.biopha.2016.04.022_bib0295","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1124\/dmd.31.6.805","article-title":"Absorption\/metabolism of sulforaphane and quercetin, and regulation of phase II enzymes, in human jejunum in vivo","volume":"31","author":"Petri","year":"2003","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.biopha.2016.04.022_bib0300","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1207\/S15327914NC382_5","article-title":"Disposition of glucosinolates and sulforaphane in humans after ingestion of steamed and fresh broccoli","volume":"38","author":"Conaway","year":"2000","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.biopha.2016.04.022_bib0305","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1089\/ars.2010.3731","article-title":"Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism","volume":"14","author":"Jazwa","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.biopha.2016.04.022_bib0310","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0009-8981(01)00727-6","article-title":"Quantitative determination of dithiocarbamates in human plasma, serum, erythrocytes and urine: pharmacokinetics of broccoli sprout isothiocyanates in humans","volume":"316","author":"Ye","year":"2002","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.biopha.2016.04.022_bib0315","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/carcin\/bgg178","article-title":"Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo","volume":"25","author":"Singh","year":"2004","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.biopha.2016.04.022_bib0320","doi-asserted-by":"crossref","first-page":"10505","DOI":"10.1021\/jf801989e","article-title":"Bioavailability and kinetics of sulforaphane in humans after consumption of cooked versus raw broccoli","volume":"56","author":"Vermeulen","year":"2008","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.biopha.2016.04.022_bib0325","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1158\/1940-6207.CAPR-10-0296","article-title":"Bioavailability of Sulforaphane from two broccoli sprout beverages: results of a short-term, cross-over clinical trial in Qidong, China","volume":"4","author":"Egner","year":"2011","journal-title":"Cancer Prev. Res. (Phila)"},{"key":"10.1016\/j.biopha.2016.04.022_bib0330","first-page":"9","volume":"64","author":"Siegel","year":"2014"},{"key":"10.1016\/j.biopha.2016.04.022_bib0335","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/mnfr.201000547","article-title":"Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells","volume":"55","author":"Clarke","year":"2011","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.biopha.2016.04.022_bib0340","doi-asserted-by":"crossref","first-page":"6855","DOI":"10.1158\/1078-0432.CCR-08-0903","article-title":"Sulforaphane enhances the therapeutic potential of TRAIL in prostate cancer orthotopic model through regulation of apoptosis, metastasis, and angiogenesis","volume":"14","author":"Shankar","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2016.04.022_bib0345","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature04870","article-title":"Nuclear factor-kappaB in cancer development and progression","volume":"441","author":"Karin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2016.04.022_bib0350","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/mc.20217","article-title":"NF-kappaB and cancer: mechanisms and targets","volume":"45","author":"Karin","year":"2006","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.biopha.2016.04.022_bib0355","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nrc1886","article-title":"Metastasis: a question of life or death","volume":"6","author":"Mehlen","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2016.04.022_bib0360","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10555-006-7886-9","article-title":"Matrix metalloproteinases and tumor metastasis","volume":"25","author":"Deryugina","year":"2006","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.biopha.2016.04.022_bib0365","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/35094009","article-title":"The development of androgen-independent prostate cancer","volume":"1","author":"Feldman","year":"2001","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2016.04.022_bib0370","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/442742a","article-title":"Cancer: the root of the problem","volume":"442","author":"Abbott","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2016.04.022_bib0375","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.molmed.2013.08.007","article-title":"TRAIL on trial: preclinical advances in cancer therapy","volume":"19","author":"Stuckey","year":"2013","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.biopha.2016.04.022_bib0380","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.3892\/ijo.2014.2335","article-title":"Sulforaphane and TRAIL induce a synergistic elimination of advanced prostate cancer stem-like cells","volume":"44","author":"Labsch","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.biopha.2016.04.022_bib0385","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/ijc.24106","article-title":"Gamma-tocopherol-enriched mixed tocopherol diet inhibits prostate carcinogenesis in TRAMP mice","volume":"124","author":"Barve","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biopha.2016.04.022_bib0390","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1080\/01635581003605896","article-title":"Mixed tocotrienols inhibit prostate carcinogenesis in TRAMP mice","volume":"62","author":"Barve","year":"2010","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.biopha.2016.04.022_bib0395","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.bcp.2013.02.010","article-title":"Sulforaphane enhances Nrf2 expression in prostate cancer TRAMP C1 cells through epigenetic regulation","volume":"85","author":"Zhang","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2016.04.022_bib0400","article-title":"The TRAMP mouse as a model for prostate cancer","volume":"20","author":"Hurwitz","year":"2001","journal-title":"Curr. Protoc. Immunol."},{"key":"10.1016\/j.biopha.2016.04.022_bib0405","doi-asserted-by":"crossref","first-page":"19911","DOI":"10.1074\/jbc.M412443200","article-title":"Sulforaphane-induced cell death in human prostate cancer cells is initiated by reactive oxygen species","volume":"280","author":"Singh","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2016.04.022_bib0410","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s10637-014-0189-z","article-title":"A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancer","volume":"33","author":"Alumkal","year":"2015","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.biopha.2016.04.022_bib0415","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1158\/1940-6207.CAPR-14-0459","article-title":"Effect of sulforaphane in men with biochemical recurrence after radical prostatectomy","volume":"8","author":"Cipolla","year":"2015","journal-title":"Cancer Prev. Res."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332215305539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332215305539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:29:18Z","timestamp":1788877758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332215305539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":83,"alternative-id":["S0753332215305539"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2016.04.022","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histone deacetylase inhibitor sulforaphane: The phytochemical with vibrant activity against prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2016.04.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}